- Home
- LEGN vs GPGI Comparison
LEGN vs GPGI Comparison
Compare LEGN & GPGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LEGN | GPGI |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.8B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LEGN | GPGI |
|---|---|---|
| Price | $19.18 | $11.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $45.62 | $20.00 |
| AVG Volume (30 Days) | ★ 1.8M | 1.4M |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 0.08% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $59,824,000.00 |
| Revenue This Year | $39.73 | $3,276.36 |
| Revenue Next Year | $23.42 | $15.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.24 | $11.17 |
| 52 Week High | $37.50 | $25.66 |
Technical Indicators
Market Signals| Indicator | LEGN | GPGI |
|---|---|---|
| Relative Strength Index (RSI) | 51.45 | 36.28 |
| Support Level | $17.08 | $11.36 |
| Resistance Level | $19.92 | $13.11 |
| Average True Range (ATR) | 0.86 | 0.62 |
| MACD | 0.11 | -0.04 |
| Stochastic Oscillator | 68.43 | 4.26 |
Price Performance
Historical ComparisonAbout LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About GPGI GPGI Inc.
GPGI Inc is a diversified holding permanent capital platform designed to acquire, own, and scale high-quality businesses that hold great positions in good industries.